These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7913896)

  • 1. Cross-linking of beta-amyloid protein precursor catalyzed by tissue transglutaminase.
    Ho GJ; Gregory EJ; Smirnova IV; Zoubine MN; Festoff BW
    FEBS Lett; 1994 Jul; 349(1):151-4. PubMed ID: 7913896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue transglutaminase in Alzheimer's disease: involvement in pathogenesis and its potential as a therapeutic target.
    Wilhelmus MM; de Jager M; Bakker EN; Drukarch B
    J Alzheimers Dis; 2014; 42 Suppl 3():S289-303. PubMed ID: 24685636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
    Gandy S; Petanceska S
    Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide.
    Dudek SM; Johnson GV
    Brain Res; 1994 Jul; 651(1-2):129-33. PubMed ID: 7922559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of Amyloid-β Protein Precursor With α- and β-Secretases in Mouse Cerebral Cortex Synapses Is Altered in Early Alzheimer's Disease.
    Pliássova A; Lopes JP; Lemos C; Oliveira CR; Cunha RA; Agostinho P
    Mol Neurobiol; 2016 Oct; 53(8):5710-21. PubMed ID: 26497029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase catalyzes differential crosslinking of small heat shock proteins and amyloid-beta.
    Boros S; Kamps B; Wunderink L; de Bruijn W; de Jong WW; Boelens WC
    FEBS Lett; 2004 Oct; 576(1-2):57-62. PubMed ID: 15474010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer beta/A4 amyloid protein by transglutaminase.
    Ikura K; Takahata K; Sasaki R
    FEBS Lett; 1993 Jul; 326(1-3):109-11. PubMed ID: 8100780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease.
    Braidy N; Essa MM; Poljak A; Selvaraju S; Al-Adawi S; Manivasagm T; Thenmozhi AJ; Ooi L; Sachdev P; Guillemin GJ
    Oncotarget; 2016 Oct; 7(40):64589-64604. PubMed ID: 27486879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amyloid peptide and its precursor in Alzheimer's disease.
    Octave JN
    Rev Neurosci; 1995; 6(4):287-316. PubMed ID: 8845971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.
    Willén K; Sroka A; Takahashi RH; Gouras GK
    J Alzheimers Dis; 2017; 60(2):511-524. PubMed ID: 28869466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic structure and function in transgenic APP mice.
    Ashe KH
    Ann N Y Acad Sci; 2000; 924():39-41. PubMed ID: 11193800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine proteases and their serpin inhibitors in Alzheimer's disease.
    Ho GJ; Smirnova IV; Akaaboune M; Hantaï D; Festoff BW
    Biomed Pharmacother; 1994; 48(7):296-304. PubMed ID: 7858160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid, dementia and Alzheimer's disease.
    Hyman BT; Tanzi RE
    Curr Opin Neurol Neurosurg; 1992 Feb; 5(1):88-93. PubMed ID: 1623244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein.
    Octave JN; Pierrot N; Ferao Santos S; Nalivaeva NN; Turner AJ
    J Neurochem; 2013 Jul; 126(2):183-90. PubMed ID: 23495999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.